Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Jonat

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Archives of Gynecology and Obstetrics|July 25, 2013
Oocyte morphology on day 0 correlates with aneuploidy as detected by polar body biopsy and FISHAndreas G Schmutzler, Bengi Acar-Perk, Jörg Weimer, et al.
Archives of Gynecology and Obstetrics|July 17, 2013
Sham-controlled implantation after preimplantation genetic screening by polar body biopsy and FISHAndreas G Schmutzler, Bengi Acar-Perk, Jörg Weimer, et al.
Journal of Cancer Research and Clinical Oncology|September 30, 2010
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell linesKaren Bräutigam, Julia Biernath-Wüpping, Dirk O Bauerschlag, et al.
Cancer Letters|January 21, 2004
Expression and regulation of tumor suppressor gene maspin in human bladder cancerShuji Sugimoto, Nicolai Maass, Yukie Takimoto, et al.
Anticancer Research|April 9, 2013
Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancerAnna-Maria Römer, Inke Lühr, Andreas Klein, et al.
Anticancer Research|October 15, 2010
Sunitinib (SU11248) inhibits growth of human ovarian cancer in xenografted miceDirk O Bauerschlag, Christian Schem, Sanjay Tiwari, et al.
International Journal of Clinical Oncology|November 18, 2015
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancerAntonia Wenners, Felix Hartmann, Arne Jochens, et al.
American Journal of Medical Genetics. Part A|February 14, 2006
Characterization of two supernumerary marker chromosomes in a patient with signs of Klinefelter syndrome, mild facial anomalies, and severe speech delayJörg Weimer, Simone Metzke-Heidemann, Hansjörg Plendl, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)Gunter von Minckwitz, Erika Graf, Matthias Geberth, et al.
Plos One|June 23, 2012
DNA-methylation profiling of fetal tissues reveals marked epigenetic differences between chorionic and amniotic samplesChristel Eckmann-Scholz, Susanne Bens, Julia Kolarova, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Archives of Gynecology and Obstetrics|July 25, 2013
Oocyte morphology on day 0 correlates with aneuploidy as detected by polar body biopsy and FISHAndreas G Schmutzler, Bengi Acar-Perk, Jörg Weimer, et al.
Archives of Gynecology and Obstetrics|July 17, 2013
Sham-controlled implantation after preimplantation genetic screening by polar body biopsy and FISHAndreas G Schmutzler, Bengi Acar-Perk, Jörg Weimer, et al.
Journal of Cancer Research and Clinical Oncology|September 30, 2010
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell linesKaren Bräutigam, Julia Biernath-Wüpping, Dirk O Bauerschlag, et al.
Cancer Letters|January 21, 2004
Expression and regulation of tumor suppressor gene maspin in human bladder cancerShuji Sugimoto, Nicolai Maass, Yukie Takimoto, et al.
Anticancer Research|April 9, 2013
Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancerAnna-Maria Römer, Inke Lühr, Andreas Klein, et al.
Anticancer Research|October 15, 2010
Sunitinib (SU11248) inhibits growth of human ovarian cancer in xenografted miceDirk O Bauerschlag, Christian Schem, Sanjay Tiwari, et al.
International Journal of Clinical Oncology|November 18, 2015
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancerAntonia Wenners, Felix Hartmann, Arne Jochens, et al.
American Journal of Medical Genetics. Part A|February 14, 2006
Characterization of two supernumerary marker chromosomes in a patient with signs of Klinefelter syndrome, mild facial anomalies, and severe speech delayJörg Weimer, Simone Metzke-Heidemann, Hansjörg Plendl, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)Gunter von Minckwitz, Erika Graf, Matthias Geberth, et al.
Plos One|June 23, 2012
DNA-methylation profiling of fetal tissues reveals marked epigenetic differences between chorionic and amniotic samplesChristel Eckmann-Scholz, Susanne Bens, Julia Kolarova, et al.
Pageof 11